X-FAB Silicon Foundries (XFAB) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
23 Dec, 2025Executive summary
Q1 revenue reached $204.1 million, down 6% year-over-year but up 8% sequentially, within guidance, with core markets representing 93% of total revenue.
Bookings rose 26% sequentially to $175 million, mainly from automotive and industrial sectors, though down 36% year-over-year.
Backlog remains elevated at $387 million, gradually declining as lead times normalize.
EBITDA was $49.1 million, up 23% sequentially and down 4% year-over-year, with a margin of 24%.
Net profit for the quarter was $12.2 million, with EPS of $0.09.
Financial highlights
Gross profit margin was 21.9%, down from 23.3% a year ago.
Operating profit nearly doubled quarter-on-quarter to $21.1 million.
Net financial result was a loss of $7.2 million, mainly due to $3.4 million in unrealized FX losses.
Cash and cash equivalents at quarter-end were $157.2 million, down 27% sequentially, in line with capex plans.
Capital expenditures were $101.7 million for the quarter.
Outlook and guidance
Q2 2025 revenue expected between $200–$210 million; EBITDA margin 22.5%–25.5%.
Full-year 2025 guidance reiterated: revenue $820–$870 million, EBITDA margin 24%–27%.
Capex for 2024 to be just below EUR 250 million, with 75% in H1.
Targeting over $1 billion revenue in 2026, driven by new products and recovery in automotive and silicon carbide.
Guidance based on USD/EUR exchange rate of 1.08 and excludes IFRS 15 impact.
Latest events from X-FAB Silicon Foundries
- Q4 revenue up 18% YoY to $222.3M; industrial and medical growth offset automotive softness.XFAB
Q4 20259 Feb 2026 - Q2 revenue fell 9% year-on-year to $205.1M; SiC weakness led to lower guidance, but Q4 rebound expected.XFAB
Q2 20242 Feb 2026 - Q3 revenue up sequentially, China automotive strong, CapEx high, full-year guidance lowered.XFAB
Q3 202418 Jan 2026 - Double-digit growth, major expansions, and $1.5B revenue and 35% margin targeted by 2030.XFAB
Investor Day 202411 Jan 2026 - Three-pillar strategy and $1.1B expansion drive growth in specialty semiconductors.XFAB
CMD 202531 Dec 2025 - 2024 saw revenue and profit declines amid destocking, but recovery and margin gains are expected.XFAB
Q4 202423 Dec 2025 - Q2 revenue up to 8% year-over-year, guidance raised, and capacity expansion completed.XFAB
Q2 202516 Nov 2025 - Q3 revenue up 11% YoY to $229M, with strong medical and industrial growth; order intake fell.XFAB
Q3 20253 Nov 2025